Cargando…
EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation
BACKGROUND: The echinoderm microtubule-associated protein-like-4 anaplastic lymphoma kinase (EML4-ALK) fusion gene was identified in a subset of non-small cell lung cancer (NSCLC) patients. They responded positively to ALK inhibitors. This study aimed to characterize the mechanisms triggered by EML4...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180148/ https://www.ncbi.nlm.nih.gov/pubmed/34090412 http://dx.doi.org/10.1186/s12890-021-01553-z |
_version_ | 1783703939487629312 |
---|---|
author | Li, Ying Li, Yongwen Zhang, Hongbing Shi, Ruifeng Zhang, Zihe Liu, Hongyu Chen, Jun |
author_facet | Li, Ying Li, Yongwen Zhang, Hongbing Shi, Ruifeng Zhang, Zihe Liu, Hongyu Chen, Jun |
author_sort | Li, Ying |
collection | PubMed |
description | BACKGROUND: The echinoderm microtubule-associated protein-like-4 anaplastic lymphoma kinase (EML4-ALK) fusion gene was identified in a subset of non-small cell lung cancer (NSCLC) patients. They responded positively to ALK inhibitors. This study aimed to characterize the mechanisms triggered by EML4-ALK to induce NSCLC transformation. METHODS: HEK293 and NIH3T3 cells were transfected with EML4-ALK variant 3 or pcDNA3.1-NC. H2228 cells were transfected with siRNA-EML4-ALK or siRNA-NC. Cell viability and proliferation were measured by the CCK-8 and EdU methods, respectively. Flow cytometry revealed apoptosis. Gene expression profiles were generated from a signaling pathway screen in EML4-ALK-regulated lung cancer cells and verified by qPCR and Western blotting. The co-immunoprecipitation and immunohistochemistry/ immunofluorescence determined the interaction and colocalization of JAK2-STAT pathway components with EML4-ALK. RESULTS: Microarray identified several genes involved in the JAK2-STAT pathway. JAK2 and STAT6 were constitutively phosphorylated in H2228 cells. EML4-ALK silencing downregulated phosphorylation of STAT6. Expression of EML4-ALK in HEK293 and NIH3T3 cells activated JAK2, STAT1, STAT3, STAT5, and STAT6. In EML4-ALK-transfected HEK293 cells and EML4-ALK-positive H2228 cells, activated STAT6 and JAK2 colocalized with ALK. STAT3 and STAT6 were phosphorylated and translocated to the nucleus of H2228 cells following IL4 or IL6 treatment. Apoptosis increased, while cell proliferation and DNA replication decreased in H2228 cells following EML4-ALK knockdown. In contrast, HEK293 cell viability increased following EML4-ALK overexpression, while H2228 cell viability significantly decreased after treatment with ALK or JAK-STAT pathway inhibitors. CONCLUSIONS: Our data suggest that the aberrant expression of EML4-ALK leads to JAK2-STAT signaling pathway activation, which is essential for the development of non-small cell lung cancer. |
format | Online Article Text |
id | pubmed-8180148 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81801482021-06-07 EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation Li, Ying Li, Yongwen Zhang, Hongbing Shi, Ruifeng Zhang, Zihe Liu, Hongyu Chen, Jun BMC Pulm Med Research Article BACKGROUND: The echinoderm microtubule-associated protein-like-4 anaplastic lymphoma kinase (EML4-ALK) fusion gene was identified in a subset of non-small cell lung cancer (NSCLC) patients. They responded positively to ALK inhibitors. This study aimed to characterize the mechanisms triggered by EML4-ALK to induce NSCLC transformation. METHODS: HEK293 and NIH3T3 cells were transfected with EML4-ALK variant 3 or pcDNA3.1-NC. H2228 cells were transfected with siRNA-EML4-ALK or siRNA-NC. Cell viability and proliferation were measured by the CCK-8 and EdU methods, respectively. Flow cytometry revealed apoptosis. Gene expression profiles were generated from a signaling pathway screen in EML4-ALK-regulated lung cancer cells and verified by qPCR and Western blotting. The co-immunoprecipitation and immunohistochemistry/ immunofluorescence determined the interaction and colocalization of JAK2-STAT pathway components with EML4-ALK. RESULTS: Microarray identified several genes involved in the JAK2-STAT pathway. JAK2 and STAT6 were constitutively phosphorylated in H2228 cells. EML4-ALK silencing downregulated phosphorylation of STAT6. Expression of EML4-ALK in HEK293 and NIH3T3 cells activated JAK2, STAT1, STAT3, STAT5, and STAT6. In EML4-ALK-transfected HEK293 cells and EML4-ALK-positive H2228 cells, activated STAT6 and JAK2 colocalized with ALK. STAT3 and STAT6 were phosphorylated and translocated to the nucleus of H2228 cells following IL4 or IL6 treatment. Apoptosis increased, while cell proliferation and DNA replication decreased in H2228 cells following EML4-ALK knockdown. In contrast, HEK293 cell viability increased following EML4-ALK overexpression, while H2228 cell viability significantly decreased after treatment with ALK or JAK-STAT pathway inhibitors. CONCLUSIONS: Our data suggest that the aberrant expression of EML4-ALK leads to JAK2-STAT signaling pathway activation, which is essential for the development of non-small cell lung cancer. BioMed Central 2021-06-06 /pmc/articles/PMC8180148/ /pubmed/34090412 http://dx.doi.org/10.1186/s12890-021-01553-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Li, Ying Li, Yongwen Zhang, Hongbing Shi, Ruifeng Zhang, Zihe Liu, Hongyu Chen, Jun EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation |
title | EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation |
title_full | EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation |
title_fullStr | EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation |
title_full_unstemmed | EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation |
title_short | EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation |
title_sort | eml4-alk-mediated activation of the jak2-stat pathway is critical for non-small cell lung cancer transformation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180148/ https://www.ncbi.nlm.nih.gov/pubmed/34090412 http://dx.doi.org/10.1186/s12890-021-01553-z |
work_keys_str_mv | AT liying eml4alkmediatedactivationofthejak2statpathwayiscriticalfornonsmallcelllungcancertransformation AT liyongwen eml4alkmediatedactivationofthejak2statpathwayiscriticalfornonsmallcelllungcancertransformation AT zhanghongbing eml4alkmediatedactivationofthejak2statpathwayiscriticalfornonsmallcelllungcancertransformation AT shiruifeng eml4alkmediatedactivationofthejak2statpathwayiscriticalfornonsmallcelllungcancertransformation AT zhangzihe eml4alkmediatedactivationofthejak2statpathwayiscriticalfornonsmallcelllungcancertransformation AT liuhongyu eml4alkmediatedactivationofthejak2statpathwayiscriticalfornonsmallcelllungcancertransformation AT chenjun eml4alkmediatedactivationofthejak2statpathwayiscriticalfornonsmallcelllungcancertransformation |